Amyris closes on potential $300M cannabinoid deal with biotech firm
Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million…
News March 19Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million…
News March 19The Supreme Court of British Columbia has approved the sale of financially troubled cannabis firm Ascent Industries for 41.5…
News March 19Statutory health insurers in Germany covered 73.7 million euros ($83.7 million) worth of medical cannabis products in 2018,…
News March 19Canadian cannabis cultivation giant Tilray plans to focus on Europe and the U.S. for its upcoming expansion plans…
News March 18Cresco Labs, a Chicago-based vertically integrated cannabis company, agreed to acquire Florida medical marijuana provider VidaCann in a…
News March 18Sales of medical marijuana oil in Canada rose steadily in the months after recreational legalization, bucking a trend…
News March 15Three weeks before the country goes to the polls, Israeli Prime Minister Benjamin Netanyahu said he would weigh legalizing…
News March 15The volume of dried adult-use cannabis sold in the regulated Canadian market fell in January while inventories continued…
News March 14North American cannabis companies have raised nearly $3.3 billion so far this year, outpacing the record funding levels…
News March 14Canadian marijuana cultivator Tilray said it is hiring former Goldman Sachs Managing Director Andrew Pucher as chief corporate development…
News March 13